REGULATED PRESS RELEASE
News
-
-
PRESS RELEASE
BIOPHYTIS et un consortium d’investisseurs incluant RONGHUI RENHE Life Technology unissent leurs forces pour financer et lancer le tout premier essai clinique de Phase 3 dans la sarcopénie
Biophytis et un consortium d'investisseurs, dont Ronghui Renhe Life Technology, s'unissent pour lancer l'essai clinique de Phase 3 en sarcopénie, avec une coentreprise à Hong-Kong -
PRESS RELEASE
Touareg Group Expands Global Presence with Establishment of U.S. Technology Subsidiary
Touareg Group expands global presence by establishing U.S. technology subsidiary, focusing on AI, blockchain, and cryptocurrency exchange platforms. Strategic growth initiative at the convergence of finance and emerging technologies -
-
-
PRESS RELEASE
Phuket en Thaïlande devient un paradis tropical pour les acheteurs européens, sous l’impulsion de Laguna Phuket et de Banyan Group Residences
Phuket, destination prisée pour les Européens en quête de biens immobiliers à l'étranger. Climat tropical, infrastructures de classe mondiale et accessibilité depuis l'Europe -
-
PRESS RELEASE
NioCorp Provides Preliminary Unaudited Financial Results for the Three-Month Period Ended September 30, 2025
NioCorp Developments Ltd. reports preliminary unaudited financial results for the three-month period ending September 30, 2025, with a record cash balance of $162.8 million and a net loss of $42.7 million -
-
PRESS RELEASE
Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the 2025 European Society for Medical Oncology Congress
Moderna's mRNA-4359 advances to Phase 2 in CPI-R/R melanoma patients. Promising data on tumor response rates and safety presented at ESMO Congress 2025
